Paris - Delayed Quote EUR
PHAXIAM Therapeutics S.A. (PHXM.PA)
0.2180
+0.0170
+(8.54%)
As of 12:58:04 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -1.98 | -0.89 |
| Low Estimate | 0 | 0 | -1.98 | -0.89 |
| High Estimate | 0 | 0 | -1.98 | -0.89 |
| Year Ago EPS | -- | -- | -5.87 | -1.98 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -1.98 | -0.89 |
| 7 Days Ago | 0 | 0 | -1.98 | -0.75 |
| 30 Days Ago | 0 | 0 | -1.98 | -0.72 |
| 60 Days Ago | 0 | 0 | -1.98 | -0.81 |
| 90 Days Ago | 0 | 0 | -1.98 | -0.84 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PHXM.PA | -- | -- | 66.26% | 55.05% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Related Tickers
ALINT.PA IntegraGen SA
0.5200
-0.38%
ALTHX.PA Theranexus Société Anonyme
0.9200
-2.15%
NANO.PA Nanobiotix S.A.
4.1050
-1.20%
DBV.PA DBV Technologies S.A.
1.5380
+3.36%
NXOA.BE Nicox SA
0.2260
0.00%
2LB.MU Iovance Biotherapeutics Inc
1.7596
+12.48%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
5CV.HA CureVac NV
3.9500
+3.62%
IPHYF Innate Pharma S.A.
1.4500
0.00%
BT1.BE Bone Therapeutics SA
0.0019
+5.56%